Article Details

FDA Approves UCLA's Heart Tissue Regeneration Drug AD-NP1 for Clinical Trials

Retrieved on: 2025-10-06 17:45:46

Tags for this article:

Click the tags to see associated articles and topics

FDA Approves UCLA's Heart Tissue Regeneration Drug AD-NP1 for Clinical Trials. View article details on hiswai:

Excerpt

The antibody's specificity ensures that it targets ENPP1 exclusively without off-target effects on other proteins. Monoclonal antibodies like AD ...

Article found on: bioengineer.org

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo